Jarom Kesler Comments on Ex Parte Review Trends at the USPTO in Bloomberg Law Interview
In an interview with Bloomberg Law, Knobbe Martens partner Jarom Kesler shared his perspective on the latest trends in institution rates of ex parte reviews (EPRs) at the U.S. Patent...
Jarom Kesler Explores Patent-Term Adjustment in the Post-Forest Era in IPWatchdog Article
In a recent article published in IPWatchdog, Knobbe Martens partner Jarom Kesler explores the impact of In re Forest, a 2025 Federal Circuit decision that addressed the question, “What value...
Carol Pitzel Cruz Comments in Law360 on Enablement Analysis in Pharmaceutical Patent Litigation
Knobbe Martens partner Carol Pitzel Cruz was quoted in a recent Law360 article on the Federal Circuit’s decision in Wyeth v. AstraZeneca, a patent infringement dispute centered on Section 112...